Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 92

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 92
---
8) the underwriter of FutureTech’s IPO is expected to represent an ownership interest of 0.9% (assuming the no redemption scenario) or 1.0% (assuming the maximum redemption scenario), in each case upon exercise thereof, and (9) the FTII Extension Loans is expected to represent an ownership interest of approximately 1.3% (assuming the no redemption scenario) or 1.3% (assuming the maximum redemption scenario), in each case thereof. These percentages (i) assume that FutureTech issues 9,217,200 shares of FutureTech Common Stock to former stockholders of Longevity as of immediately prior to the Closing, (ii) include the impact of the exercise of all Warrants that will be outstanding following the Business Combination and (iii) assume the Closing occurs on [●], 2025. If the actual facts are different from these assumptions, the percentage ownership retained by FutureTech’s existing public stockholders in the combined company will be different.

In addition, Longevity employees and consultants hold, and after Business Combination, are expected to be granted, equity awards under the Equity Incentive Plan. You will experience additional dilution when those equity awards become vested and settled or exercisable, as applicable, for shares of FutureTech Common Stock.

The issuance of additional common stock will significantly dilute the equity interests of existing holders of FutureTech securities and may adversely affect prevailing market prices for our public shares or public warrants.

Upon completion of the Business Combination, the Sponsor will beneficially own a significant equity interest and may take actions that conflict with the interests of FutureTech’s public stockholders. The interests of the Sponsor may not align with the interests of FutureTech’s public stockholders in the future. The Sponsor and its affiliates are in the business of making investments in companies and may acquire and hold interests in businesses that compete directly or indirectly with FutureTech. The Sponsor and its affiliates, may also pursue acquisition opportunities that may be complementary to FutureTech’s business and, as a result, those acquisition opportunities may not be available to the combined company. In addition, the Sponsor may have an interest in pursuing acquisitions, divestitures and other transactions that, in their judgment, could enhance their investment, even though such transactions might involve risks to the combined company and its stockholders.

| 33 |

Warrants will become exercisable for FutureTech Common Stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to stockholders.

Outstanding warrants to